Daniel Bradbury

Independent Director

Member of the Board of Directors since: 2016
Year of birth: 1961
Nationality: U.S.

Professional Experience

• Executive Chairman, former CEO and Co-Founder of Equillium Inc., a company developing products to treat severe autoimmune and inflammatory disorders
• Managing Member, BioBrit LLC
• Member, Board of Trustees, Keck Graduate Institute, U.S.
• Director, Intercept Pharmaceuticals and several private companies and philanthropic organizations
• Board Chairman, Castle Biosciences Inc & Biolinq
• Member, Advisory Council, Rady School of Management, San Diego, U.S.
• Life sciences executive with over 38 years of experience in creating and implementing strategies and transforming businesses
• Former CEO, Amylin Pharmaceuticals, a leading metabolic disease company, acquired by Bristol Myers Squibb in 2012

Recognitions

• Recipient of Director of the Year Award from Corporate Directors Forum (2012)
• EY’s Entrepreneur of the Year Finalist (2012)

Education

• International Executive Program, INSEAD, France
• Diploma in Management Studies, Harrow and Ealing Colleges of Higher Education, UK
• Bachelor of Pharmacy, Nottingham University, UK